Quarterly report · Q1
2269.TEDINET S100OXYQ
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥247.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥235.9bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥18.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥18.6bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥18.4bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥19.1bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥23.2bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥19.1bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥16.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.5bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥16.2bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥13.2bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥1.14T | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥1.12T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.10T | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥419.0bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥404.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥725.4bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥713.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥663.8bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥87.8bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥67.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥84.9bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥68.1bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥39.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥4.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.2bn | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.5bn | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥22.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥36.0bn | 2021-04-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥113.73 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥607.24 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.09 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.2% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥140m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥278m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥204.4bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥204.3bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥131m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥14.5bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥42.9bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥247.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥247.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥140m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥18.3bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥206m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥206m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥163m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥199.9bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥199.8bn |
| jpcrp040300-q1r_E21902-000Foodreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥124m |
| jpcrp040300-q1r_E21902-000Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥19.4bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥36.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥36.2bn |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥81m |
| jpcrp040300-q1r_E21902-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥638m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥236.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥235.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥206m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥18.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 512
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration | 247131000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E21902-000FoodReportableSegmentsMember | 131000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E21902-000PharmaceuticalsReportableSegmentsMember | 9000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 140000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -140000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E21902-000FoodReportableSegmentsMember | 204387000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E21902-000PharmaceuticalsReportableSegmentsMember | 42884000000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 247272000000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -140000000 | JPY |
| Net sales | CurrentYTDDuration | 247131000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E21902-000FoodReportableSegmentsMember | 14507000000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E21902-000PharmaceuticalsReportableSegmentsMember | 3815000000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 18322000000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -278000000 | JPY |
| Operating income | CurrentYTDDuration | 18044000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の4の7第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第14期第1四半期(自 2022年4月1日 至 2022年6月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)明治ホールディングス株式会社 | |
| Company name in english cover page | FilingDateInstant | Meiji Holdings Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 社長 CEO 川村 和夫 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋二丁目4番16号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03(3273)4001(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営管理部長 島田 勇人 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋二丁目4番16号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03(3273)4001(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)経営管理部長 島田 勇人 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E21902 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 22690 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)明治ホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Meiji Holdings Co.,Ltd. | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | - | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-06-30 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |